Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany The Dak-gesundheit Intends To Conclude A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Tocilizumab (only Pre-filled Syringe And Pre-filled Pen), Atc L04ac07 For The Period From 01.12.2025 To 30.11.2027. This I 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Fluticasone In The Dosage Form Ihp And From An Effective Strength Of 0.25 Mg. 2026-04-22
Germany Open House Original Discount Contracts 202533 Propranolol (dosage Form 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pantoprazole As An Otc Medicine. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph 8 Sgb V With The Active Ingredient Metoprolol In The Dosage Form Ret And The Effective Strength 50mg. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Octreotide In The Dosage Forms Pls And Trs. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph 8 Sgb V With The Active Ingredient Omeprazole As An Otc Medicine. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ipratropium Bromide. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Isosorbide Mononitrate, The Dosage Forms Ret/rek And Selected Strengths. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Methylphenidate In Selected Strengths And Dosage Forms. 2026-04-22
Whats app